Analyzers
Cytometry
Flow cytometers that identify, count, and characterize cells to support cell analysis. From easy to use benchtop spectral systems to high-parameter spectral analyzer / flow cytometer up to 7 lasers and 188 detectors.
See AnalyzersCell Sorters
Cytometry
Flow cytometers Cell Sorters fully automated up to 12 colors with microfluidics sorting and a benchtop fit to make it a good fit for individual labs or core facilities.
See Cell SortersReagents
Flow Cytometry
The advent of spectral cytometry, as well as the ever increasing availability of new fluorochromes, have expanded applications and capabilities beyond conventional flow cytometry.
See ReagentsCytosens partner Sony Biotechnologies
Cytosens is born from 10 years of experience in Flow Cytometry field. the intention of being the reference company for all the cytometry laboratories, offering cutting-edge technologies, has given birth to the partnership with Sony Biotechnology.Cytosens is an authorized distributor of Sony Biotechnology products, flow cytometers, cell sorters and cytometry reagents in Italy. Thanks to the partnership with the major brands and major companies producing reagents for cellular analysis, Cytosens offers the complete solution for your FACS analyzes.
Software per Cytometria
Bridging The Gap Between Cytometry and Results
FCS Express gets you from raw data to easily-understandable, beautifully formatted, presentation-ready results more easily and in less time than any other flow cytometry software.Experience the Difference »
Flow Cytometry News: instruments, reagents, tools and events
4 Dicembre, 2019
Join this educational webinar to learn from an eminent researcher, how Single-Cell Combinatorial Indexing (SCI) can be used for assessment of the open chromatin landscape of […]
6 Novembre, 2019
The International Workshop will be focused on Flow Cytometry applications in fields others than bio-medicals, herewith named “exotic”, as foods, environmental microbiology, plant and animal analysis […]
24 Ottobre, 2019
This webinar will focus on new technologies for isolating and profiling tumor cells. Although immune-based therapies targeting the inhibitory receptors (PD-L1, PD1, and CTLA4) are proven […]
